Literature DB >> 18489906

Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes.

David Jung1, Jon Paul Powers, Suzana K Straus, Robert E W Hancock.   

Abstract

Daptomycin is a cyclic anionic lipopeptide with an antibiotic activity that is completely dependent on the presence of calcium (as Ca2+). In a previous study [Jung et al., 2004. Chem. Biol. 11, 949-957], it was concluded that daptomycin underwent two Ca2+-dependent structural transitions, whereby the first transition was solely dependent on Ca2+, while the second transition was dependent on both Ca2+ and the presence of negatively charged lipids that allowed daptomycin to insert into and perturb bilayer membranes with acidic character. Differences in the interaction of daptomycin with acidic and neutral membranes were further investigated by spectroscopic means. The lack of quenching of intrinsic fluorescence by the water-soluble quencher, KI, confirmed the insertion of the daptomycin Trp residue into the membrane bilayer, while the kynurenine residue was inaccessible even in an aqueous environment. Differential scanning calorimetry (DSC) indicated that the binding of daptomycin to neutral bilayers occurred through a combination of electrostatic and hydrophobic interactions, while the binding of daptomycin to bilayers containing acidic lipids primarily involved electrostatic interactions. The binding of daptomycin to acidic membranes led to the induction of non-lamellar lipid phases and membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18489906     DOI: 10.1016/j.chemphyslip.2008.04.004

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  25 in total

1.  Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins.

Authors:  Joe Pogliano; Nicolas Pogliano; Jared A Silverman
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.

Authors:  Mark A Kreutzberger; Antje Pokorny; Paulo F Almeida
Journal:  Langmuir       Date:  2017-11-13       Impact factor: 3.882

3.  Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.

Authors:  Wiebke Arendt; Stefanie Hebecker; Sonja Jäger; Manfred Nimtz; Jürgen Moser
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

4.  Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Authors:  Dominique Dugourd; Haiyan Yang; Melissa Elliott; Raymond Siu; Jacob J Clement; Suzana K Straus; Robert E W Hancock; Evelina Rubinchik
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

5.  Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance.

Authors:  Corwin Miller; Jiayi Kong; Truc T Tran; Cesar A Arias; Gerda Saxer; Yousif Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

6.  An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.

Authors:  Longzhu Cui; Taisuke Isii; Minoru Fukuda; Tomonori Ochiai; Hui-Min Neoh; Ilana Lopes Baratella da Cunha Camargo; Yukiko Watanabe; Mitsutaka Shoji; Tomomi Hishinuma; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

7.  Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.

Authors:  Julia Preu; Timo Jaeger; Vasil M Garamus; Thomas Gutberlet
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

8.  Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.

Authors:  E Rubinchik; T Schneider; M Elliott; W R P Scott; J Pan; C Anklin; H Yang; D Dugourd; A Müller; K Gries; S K Straus; H G Sahl; R E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

Review 9.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.

Authors:  Kien T Nguyen; Xiaowei He; Dylan C Alexander; Chen Li; Jian-Qiao Gu; Carmela Mascio; Andrew Van Praagh; Larry Mortin; Min Chu; Jared A Silverman; Paul Brian; Richard H Baltz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.